Amylyx Pharmaceuticals Inc.
03/26/2025 | Press release | Distributed by Public on 03/27/2025 04:02
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
|
|||||||
Amylyx Pharmaceuticals Inc. published this content on March 26, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on March 27, 2025 at 10:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]